Namenda XR — Class III drug recall D-1064-2014
Terminated recall by Forest Pharmaceuticals Inc, reported 2014-02-12, distributed nationwide. Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution te
| Recall number | D-1064-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Forest Pharmaceuticals Inc, Earth City, MO, United States |
| Recall initiated | 2013-11-13 |
| Classified | 2014-02-04 |
| Reported by FDA | 2014-02-12 |
| Terminated | 2014-05-07 |
| Distributed | Nationwide (US) |
| Quantity | 3,950 packages |
| Reason classes | specification failure |
| NDC | 00456-3400-29 |
| Lot numbers | 01/15, 1113661 |
Product
Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titration pack,Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3400-29.
Reason for recall
Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1064-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.